Cargando…
Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522720/ https://www.ncbi.nlm.nih.gov/pubmed/36163540 http://dx.doi.org/10.1007/s40273-022-01184-0 |
| _version_ | 1784800119085858816 |
|---|---|
| author | Giannelos, Nikolaos Nishimwe, Marie Libérée Lecrenier, Nicolas |
| author_facet | Giannelos, Nikolaos Nishimwe, Marie Libérée Lecrenier, Nicolas |
| author_sort | Giannelos, Nikolaos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9522720 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95227202022-10-01 Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” Giannelos, Nikolaos Nishimwe, Marie Libérée Lecrenier, Nicolas Pharmacoeconomics Letter to the Editor Springer International Publishing 2022-09-26 2022 /pmc/articles/PMC9522720/ /pubmed/36163540 http://dx.doi.org/10.1007/s40273-022-01184-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Giannelos, Nikolaos Nishimwe, Marie Libérée Lecrenier, Nicolas Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title | Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title_full | Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title_fullStr | Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title_full_unstemmed | Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title_short | Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” |
| title_sort | comment on “cost-effectiveness analysis of herpes zoster vaccination in 50- to 85-year-old immunocompetent belgian cohorts: a comparison between no vaccination, the adjuvanted subunit vaccine, and live-attenuated vaccine” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522720/ https://www.ncbi.nlm.nih.gov/pubmed/36163540 http://dx.doi.org/10.1007/s40273-022-01184-0 |
| work_keys_str_mv | AT giannelosnikolaos commentoncosteffectivenessanalysisofherpeszostervaccinationin50to85yearoldimmunocompetentbelgiancohortsacomparisonbetweennovaccinationtheadjuvantedsubunitvaccineandliveattenuatedvaccine AT nishimwemarieliberee commentoncosteffectivenessanalysisofherpeszostervaccinationin50to85yearoldimmunocompetentbelgiancohortsacomparisonbetweennovaccinationtheadjuvantedsubunitvaccineandliveattenuatedvaccine AT lecreniernicolas commentoncosteffectivenessanalysisofherpeszostervaccinationin50to85yearoldimmunocompetentbelgiancohortsacomparisonbetweennovaccinationtheadjuvantedsubunitvaccineandliveattenuatedvaccine |